Galapagos nv Company Profile

11:31 EDT 20th March 2018 | BioPortfolio

Galapagos was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. From the start, Galapagos has operated a hybrid business model, combining internal discovery programs with service activities. The joint venture operated until 2002 when the Company raised €23.4 million in a private placement. In May 2005, the Company raised €22.4 million through its initial public offering on the Euronext Brussels (Ticker symbol: GLPG) and Euronext Amsterdam (GLPGA) stock exchanges. In October 2005, Galapagos acquired BioFocus, a drug discovery company based in Saffron Walden, UK, through an all share offer, giving BioFocus shareholders a 29% state holding in the enlarged Company. On October 20, 2005 Galapagos started trading on the Alternative Investment Market of the London Stock exchange (Ticker symbol: GLPG). On June 13, 2006 Galapagos announced the acquisition of the drug discovery operations of Discovery Partners International, forming the new drug discovery division called BioFocus DPI.


Industriepark Mechelen Noord Generaal De Wittelaan L11 A3


Phone: 32 15 34 29 00
Fax: 32 15 34 29 01

News Articles [75 Associated News Articles listed on BioPortfolio]

Galapagos: 3 Pillars to Success, The Galapagos Model

In this episode of PharmaTelevision News Review,filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Onno Van De Stolpe, CEO of Galapagos

Galapagos: Technology Platforms and Future Plans

In this episode of PharmaTelevision News Review, Fintan Walton talks with Onno Van de Stolpe, CEO at Galapagos. Filmed at BioBusiness 2010 in London, England, they discuss: • How Galapagos has handl...

Galapagos NV: Consistent safety findings and durable activity with filgotinib treatment of rheumatoid arthritis patients up to week 84 in DARWIN 3 study

Galapagos presents data from DARWIN 3, other filgotinib studies and Galapagos' GLPG1972 at American College of Rheumatology Meeting 2017 Mechelen, Belgium; 5 November 2017; 3 PM CET - Galapagos NV...

Galapagos: Onno van de Stolpe, CEO

Onno van de Stolpe talks to Fintan Walton, about Galapagos' current business model and overall strategic outlook. They discuss the integration of BioFocus following its acquisition by Galapagos in Nov...

Galapagos to co-promote JAK-1 inhibitor if approved for IBD, RA

Biotech company Galapagos has opted to co-promote filgotinib with its partner Gilead Sciences should the drug be approved in Europe, according to a press release.Filgotinib is an investigational oral ...

Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout

Galapagos’ will receive a $10M (€8.5M) milestone payment from its collaborator, AbbVie, after their cystic fibrosis candidate started a Phase I trial. Galapagos is a clinical-stage biotech d...

BRIEF—Collaboration gives Galapagos rights to MALT1 inhibitors

Belgo-Dutch biotech Galapagos has teamed up with a research institute and Belgium’s Centre for Drug…

Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA

Galapagos and ProQR will work together to target fibrosis using a technology to treat genetic diseases without permanent changes to the DNA. A new research collaboration between two biotech companies ...

Drugs and Medications [0 Results]


PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Genetic Pedigree Analysis of the Pilot Breeding Program for the Rediscovered Galapagos Giant Tortoise from Floreana Island.

An aim of many captive breeding programs is to increase population sizes for reintroduction and establishment of self-sustaining wild populations. Genetic analyses play a critical role in these progra...

Residency and movement patterns of an apex predatory shark (Galeocerdo cuvier) at the Galapagos Marine Reserve.

The potential effectiveness of marine protected areas (MPAs) as a conservation tool for large sharks has been questioned due to the limited spatial extent of most MPAs in contrast to the complex life ...

Alien species pathways to the Galapagos Islands, Ecuador.

Alien species, one of the biggest threats to natural ecosystems worldwide, are of particular concern for oceanic archipelagos such as Galápagos. To enable more effective management of alien species, ...

Intraspecific variation in feeding strategies of Galapagos sea lions: A case of trophic specialization.

The trophic behavior of marine predators varies according to the level of competition to which they are exposed. In general, populations that inhabit lower productivity systems face a strong intraspec...

Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

Galapagos nv

Galapagos was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. From the start, Galapagos has operated a hybrid business model, combining internal discovery programs...

Discovery Partners International

Discovery Partners recently completed the sale of all of the stock of Discovery Partners’ operating subsidiaries and all of Discovery Partners’ material operating assets pursuant to a stock and as...


We are a genomics based drug discovery company, that has drug discovery programs based on proprietary disease modifying drug targets. Our vision is to bring novel drugs to the market in selected disea...

More Information about "Galapagos nv" on BioPortfolio

We have published hundreds of Galapagos nv news stories on BioPortfolio along with dozens of Galapagos nv Clinical Trials and PubMed Articles about Galapagos nv for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Galapagos nv Companies in our database. You can also find out about relevant Galapagos nv Drugs and Medications on this site too.

Quick Search


Relevant Topics

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record